Antares Pharma Inc (ATRS)

2.51
0.04 1.57
NASDAQ : Health Care
Prev Close 2.55
Open 2.55
Day Low/High 2.48 / 2.56
52 Wk Low/High 0.67 / 2.25
Volume 652.22K
Avg Volume 1.35M
Exchange NASDAQ
Shares Outstanding 155.93M
Market Cap 397.61M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Summary

We initiated one new position and exited another last week, while several other names reported earnings.

Digging Into Amplify and Antares Results

BETR and ATRS report March-quarter numbers. Plus, post-call commentary on USA Technologies.

Antares Pharma Reports First Quarter 2017 Operating And Financial Results

Multiple Drug Device Combination Products Pending FDA Approval

Stocks Under $10 Weekly Summary

We add a new name to the portfolio during a busy week of earnings.

Stocks Under $10 Weekly Summary

During a busy week of earnings and data, we exited 2 positions and initiated a small one.

Don't Be Surprised If Dip Buyers Jump In on Any Pullback

Don't Be Surprised If Dip Buyers Jump In on Any Pullback

We'll see what happens in the way of reaction to Trump's tax policy this afternoon, but if we sell off I'm likely going to be a buyer.

Stocks Under $10 Weekly Summary

We exited one position and downgraded another as earnings season heated up.

Stocks Under $10 Weekly Summary

We added a new name to the portfolio as the market took a breather in a shortened trading week.

Stocks Under $10 Weekly Summary

Chris Versace runs down the portfolio.

Stocks Under $10 Weekly Summary

We beat the benchmark Russell 2000 for the quarter, and we await a busy week on the economic front.

Stocks Under $10 Weekly Summary

We are keeping an eye on rate-sensitive names for possible buying opportunities, as stocks fell around 1.5% this week.

First Week of November 17th Options Trading For Antares Pharma (ATRS)

Investors in Antares Pharma Inc. saw new options begin trading this week, for the November 17th expiration.

Stocks Under $10 Weekly Summary

We picked up more Abraxas Petroleum on weakness, while the market rebounded slightly after the FOMC announced the anticipated quarter-point rate hike.

Quarter Gives Antares Pharma a 'QuickShot'

With the stock jumping on 4Q results, we'll lower our rating.

Stocks Under $10 Weekly Summary

We bulked up on Abraxas Petroleum and Yamana Gold on weakness, as the markets pulled back and investors positioned for next week’s FOMC meeting.

Stocks Under $10 Weekly Summary

We booked some profits in Huntington Bancshares and Builders FirstSource, while markets digested the likelihood of a March rate hike.

Stocks Under $10 Weekly Summary

We opened a new position in Abraxas Petroleum on its above-average growth potential, as stocks faced selling pressure this week.

Stocks Under $10 Weekly Summary

We closed out our position in OraSure Technologies for an average gain of 105% gain.

Stocks Under $10 Weekly Summary

We used some of the proceeds to boost our stake in Jive Software this week. In addition, we initiated a position in drug-delivery system developer, Antares Pharma.

Injecting Some Testosterone Into the Portfolio

We're initiating a position in drug-delivery system developer Antares Pharma, which we think can double from current levels.